CoChat
Sign Up
Cited by 137Schizophrenia research and treatmentBipolar Disorder and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study

Open access
Rajkumar, Anto P., Horsdal, Henriette Thisted, Wimberley, Theresa, Cohen, Dan, Mors, Ole, Børglum, Anders D., Gasse, Christiane·2017·American Journal of Psychiatry
DOI 10.1176/appi.ajp.2016.16040442
Open this paper in CoChat — free accountOpen PDF

Abstract

OBJECTIVE: Diabetes mellitus contributes to excessive cardiovascular deaths and reduced life expectancy in schizophrenia. This population-based cohort study investigated the endogenous risk for diabetes in antipsychotic-naive schizophrenia and evaluated the risks added by starting antipsychotic treatment in people with schizophrenia. METHOD: The study followed all people born in Denmark on or after Jan. 1, 1977, until Jan. 1, 2013 (N=2,736,510). The Danish Psychiatric Central Research Register ascertained schizophrenia diagnoses. The Danish National Prescription Registry provided data on prescriptions of antipsychotics. Diabetes was ascertained from the Danish National Patient Register and Danish National Prescription Registry. The authors estimated the endogenous and antipsychotic-related risks for diabetes by using Cox proportional hazards regression models, while accounting for potential confounders. RESULTS: Of the cohort members, 14,118 (0.52%) developed diabetes, and 8,945 (0.33%) developed schizophrenia during follow-up (49,582,279 person-years). The adjusted hazard ratio for diabetes was 3.07 (95% confidence interval [CI], 1.71-5.41) in antipsychotic-naive schizophrenia compared with the general population. The risk for diabetes after starting antipsychotic treatment was significantly higher (adjusted hazard ratio, 3.64; 95% CI, 1.95-6.82) than the risk in antipsychotic-naive schizophrenia, after adjustment for family history of diabetes and other potential confounders. First-line treatment with either first-generation antipsychotics (adjusted hazard ratio, 3.06; 95% CI, 1.32-7.05) or second-generation antipsychotics (adjusted hazard ratio, 3.44; 95% CI, 1.73-6.83) increased the risk for diabetes without a statistically significant difference. Appropriate sensitivity analyses limited to type 2 diabetes corroborated these results. CONCLUSIONS: Schizophrenia confers a high endogenous risk for diabetes, and the risk is further increased by both first-generation and second-generation antipsychotics. Early detection and effective treatment of diabetes should be an integral part of multidisciplinary management of schizophrenia regardless of antipsychotic drug exposure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2016.16040442

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Research works printed but not linked: 8

  1. Maudsley H, 1879, The Pathology of Mind
  2. Baker RA, 2009, Psychopharmacol Bull, 42, 11
  3. Davis S., 2010, S Afr Pharm J, 77, 22
  4. WHO, 1967, Manual of the International Classification of Diseases, Eighth Revision (ICD-8)
  5. WHO, 1992, The ICD-10 Classification of Mental and Behavioural Disorders—Diagnostic Criteria for Research
  6. Elks ML, 1993, West J Med, 159, 44
  7. WHO, 2014, Guidelines for ATC Classification and DDD Assignment, 2015
  8. Uggerby P, 2013, Dan Med J, 60, A4578

Cited by

Sorted by citations

Items 101–137 of 137

Related

See all

Metadata

Authors
Rajkumar, A. P., Horsdal, H. T., Wimberley, T., Cohen, D., Mors, O., Børglum, A. D., & Gasse, C.
Affiliations
King's College London (GB)
ORCID
Venue
American Journal of Psychiatry
Publisher
American Psychiatric Association Publishing
Published
2017-07-01
Volume
174
Issue
7
Pages
686-694
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
DOI
10.1176/appi.ajp.2016.16040442
OpenAlex
W2579288121
Cited by
137
References
53
Citations by year
2026: 12 · 2025: 12 · 2024: 14 · 2023: 13 · 2022: 13 · 2021: 15 · 2020: 12 · 2019: 23 · 2018: 12 · 2017: 10
FWCI
12.81
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (acceptedVersion, other-oa)
  • Repository@Nottingham (University of Nottingham) (acceptedVersion, other-oa)
  • Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
Funders
  • Eli Lilly and Company
  • Aarhus Universitet
  • Aarhus Universitetshospital
  • National Institute for Health and Care Research (CL-2015-17-008)
  • King's College London
  • European Commission (279227)
  • Lundbeckfonden (R155-2014-1724)
  • Sundhedsstyrelsen
  • H. Lundbeck A/S
  • Menzies Centre for Australian Studies, King's College London, University of London
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
schizophrenia, diabetes mellitus, antipsychotic drugs, typical antipsychotics, atypical antipsychotics, type 2 diabetes, youth, cardiovascular risk
MeSH terms
Adult, Denmark, Diabetes Mellitus, Female, Humans, Male, Registries, Risk Factors, Schizophrenia, Antipsychotic Agents, Cohort Studies, Proportional Hazards Models, Early Diagnosis, Young Adult, Early Medical Intervention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review